Searched for
PHARMA SECTOR INCENTIVES
If FIIs return, they tend to see it first. 15 stocks from financial services ecosystem, with upside potential as low as 3% to as high as 28%Financial services is where FIIs go when they turn positive on India. History shows us that much of the money goes to banks, and the wider ...- Delayed monsoon may weigh on auto demand, but long-term outlook stays strong: Aditya ShahA delayed monsoon poses a temporary challenge to rural auto demand, particularly for tractors and two-wheelers, but the sector's long-term ...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Rs 1,100 crore a day nightmare: Why FIIs are ruthlessly selling bank stocksForeign investors are aggressively selling Indian bank stocks, offloading over ₹1,100 crore daily due to global economic pressures and port...
- India, Uzbekistan aim to double bilateral trade in 3 yearsIndia and Uzbekistan are set to significantly boost bilateral trade, aiming to double it within three years. Discussions at the recent Inte...
- India's productivity gap with China widens despite strong GDP growth; manufacturing leap still missing: ReportIndia's labour productivity gap with China has widened significantly since 2000, despite strong economic growth. The country has yet to ach...
- Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...
- NSE sector indices: Metals and energy lead long-term performance; defensives lagWelcome to TrendMap, your guide to the performance of different investment segments. In this edition, we present a 10-year performance trac...
- MSMEs key to creating 20 lakh jobs in Andhra: Minister Nara LokeshThe government is promoting decentralized development through clusters and simplifying business processes. Plans are underway to list 100 A...
- Budget 2026 wish-list: Pharma sector seeks API self-reliance, export incentives to strengthen India’s ‘Pharmacy of the World’ tagAhead of the Union Budget 2026, pharma players push for API self-reliance and export competitiveness.
- PLI scheme: Electronics, pharma receive 70% of total disbursements for FY25Out of a total of Rs 10,114 crore disbursed by the government for the year 2024-25, the two sectors -- electronics and pharma -- got Rs 5,7...
- Govt disburses Rs 14,020 crore in ten PLI schemes so farApproved for 764 applications, these schemes have generated significant investments, production, and exports. Sectors like specialty steel ...
- Govt disburses Rs 14,020 crore in ten PLI schemes so farThe government has disbursed Rs 14,020 crore under Production-Linked Incentive (PLI) schemes across ten sectors, boosting domestic manufact...
- 50 new plants to come up in 2 yrs under pharma, medical device PLI scheme: OfficialThe Indian government plans to establish 50 new greenfield pharma and medical device plants under the PLI scheme within two years. This fol...
- Govt mulls tweaking PLI schemes in textiles, food processing, pharma: OfficialThe scheme was announced in 2021 for 14 sectors, including telecommunication, white goods, textiles, manufacturing of medical devices, auto...
- PLI: Rs 4,415 cr disbursed, system in place to facilitate beneficiaries’ visa applicationsThe Indian government has disbursed approximately Rs 4,415 crore under the Production-Linked Incentive (PLI) schemes for eight sectors, inc...
- Venus Remedies surges 13% on govt's PLI nodIn a release last month, the Ministry of Chemicals and Fertilisers said that 55 companies had qualified for the PLI scheme for the pharmace...
- Best time to invest in pharma, medical device sector: DV Sadananda GowdaThe Indian pharma sector, currently valued at USD 40 billion, has the potential to become a global pharmacy hub in the coming years, the Ch...
- Budget 2015: R&D activities in pharma may get tax boostIn its Budget proposals, the Commerce Ministry has sought "weighted average tax benefit of 400 per cent for R&D activities for the sector",...
- Better pillsEmployees of smaller pharmaceutical and biotech companies are no more children of a lesser God. As business booms and the big dozen in Indi...
Load More
